Login / Signup

Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder.

Maja DobrosavljevicSeena FazelEbba Du RietzLin LiLe ZhangZheng ChangTomas JernbergStephen V FaraoneJohan JendleQi ChenIsabell BrikellHenrik Larsson
Published in: Evidence-based mental health (2022)
Individuals initiating pharmacological treatment of ADHD at higher risk of developing CVDs should be more closely monitored.
Keyphrases
  • attention deficit hyperactivity disorder
  • autism spectrum disorder
  • cardiovascular disease
  • working memory
  • type diabetes
  • metabolic syndrome